Skip navigation

Professor Cliona Rooney

"Immunology is as much an art as a science: visual in its concepts, philosophical in its interpretations, and rather beautiful in its truths", this is how Cliona M. Rooney describes her passion for immunology. That passion took hold when she was a student and has never left her since. Cliona Rooney is a recognized expert in the field of cytotoxic T cell lymphocytes, which play a key role in a number of autoimmune diseases. Her achievements include the development of clinical guidelines for the treatment of malignant lymphomas caused by the Epstein-Barr virus. These lymphomas can develop in patients after stem cell transplantation. Currently, Cliona Rooney is investigating how T cells can be made resistant to certain ligands, along with other topics.


Education

  • 1985-87: Postdoc, Yale University (School of Medicine), USA
  • 1981-85: Post-doc, Universities of Bristol (Department of Pathology) and Birmingham (Department of Cancer Studies), England
  • 1981: Ph.D. in Immunology, University of Cambridge, England


Professional History

  • Since 1998: Professor - (joint appointment), Baylor College of Medicine, Department of Pediatrics, Hematology/Oncology Section, and Department of Molecular Virology and Microbiology, Houston, Texas, USA
  • Member, Baylor College of Medicine, Shell Center for Cell and Gene Therapy, Houston, Texas, USA
  • 1987-98: Associate Professor, Department of Virology and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA


Memberships & Editorships

  • Member, International Association for EBV and Associated Malignant Diseases
  • Member, American Society of Gene Therapy
  • Member, American Society of Virology
  • Member, New York Academy of Sciences